News details

 
Information title

Merck invests $300M in vaccine expansion; Bayer taps new chief;

Published on Friday 25 July 2008 - 15:03

Summary :
> Merck's decision to pump $300 million into an expansion of its Durham, NC vaccine facility is seen by analysts as part of a coordinated effort to solidify a leading role in a booming global...
Read more

Information source

http://www.fiercebiotech.com/news/frontpage

Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry

Articles published on this website : 1 / 7 days - 4 / 30 days

Roche snaps up Memory Pharma for $50M Merck drug fails to improve Alzheimer's symptoms TorreyPines sells Alzheimer's rights to Eisai Medivation hands out big bonuses after Pfizer deal Fidelity invests $65 in EnVivo Pharma, takes over

Other articles published on other websites on the same day

Alzheimer's: Have Many Grains of Salt Ready http://blog.newsweek.com/ Putting a Price on Innovation http://www.portfolio.com/ New Alzheimer's drug inspires hope http://www.stuff.co.nz/ Letter to the Editor http://www.greene-news.com/ The Friday Buffet http://chicagoist.com/ ICAD 2008: Alzheimer's Association International Conference on Alzheimer's Disease http://www.medscape.com/ A Bad Mix - Cell Phones and Children? http://brainblogger.com/ Alzheimer's & Dementia: The Journal of the Alzheimer's Association Accepted for Coverage in MEDLINE http://www.webwire.com/ Neurotherapeutics Presents Special Issue on New Treatments for Alzheimer's Disease http://www.webwire.com/ Alvaro Fernandez: Top 10 Brain Training Predictions http://www.huffingtonpost.com/